Challenge to be first in a series to crowdsource Alzheimer’s data for new disease insights .
November 11, 2013 by
November 7, 2013 by
The IP & Science Business of Thomson Reuters has announced a strategic initiative with NuMedii. The companies will leverage high-quality data, knowledge and predictive technologies to identify therapeutic candidates with the greatest probability for clinical success.
In this special guest feature, Saar Bitner of SiSense discusses the history and current state of BI software, and how things are starting to change to better address the needs of the business user. [Read More...]